{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:37:04Z","timestamp":1792121824057,"version":"4.4.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.autrev.2010.02.006","type":"journal-article","created":{"date-parts":[[2010,2,15]],"date-time":"2010-02-15T09:36:50Z","timestamp":1266226610000},"page":"483-487","source":"Crossref","is-referenced-by-count":55,"title":["Wegener's Granulomatosis vasculitis and granuloma"],"prefix":"10.1016","volume":"9","author":[{"given":"Anna M.","family":"Schilder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2010.02.006_bib1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1196\/annals.1361.042","article-title":"Is PR3-ANCA formation initiated in Wegener's granulomatosis lesions?","volume":"1051","author":"Voswinkel","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2010.02.006_bib2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.autrev.2008.07.020","article-title":"Vasculitis and infections: contribution to the issue of autoimmunity reviews devoted to \u201cautoimmunity and infection\u201d","volume":"8","author":"Kallenberg","year":"2008","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2010.02.006_bib3","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/rheumatology\/kem107","article-title":"Prevalence of Wegener's granulomatosis, microscopic polyangiitis, polyarteritis nodosa and Churg Strauss syndrome within a defined population in Southern Sweden","volume":"46","author":"Mohammad","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2010.02.006_bib4","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/thx.54.7.629","article-title":"Rare diseases. 3: Wegener's granulomatosis","volume":"54","author":"Langford","year":"1999","journal-title":"Thorax"},{"key":"10.1016\/j.autrev.2010.02.006_bib5","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/1529-0131(199809)41:9<1521::AID-ART2>3.0.CO;2-A","article-title":"Antineutrophil cytoplasmic antibodies","volume":"41","author":"Hoffman","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2010.02.006_bib6","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1002\/art.11075","article-title":"Limited versus severe Wegener's granulomatosis: baseline data on patients in the Wegener's granulomatosis etanercept trial","volume":"48","author":"Stone","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2010.02.006_bib7","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1136\/bmj.2.5091.265","article-title":"Giant cell granuloma of the respiratory tract (Wegener's granulomatosis)","volume":"34","author":"Walton","year":"1958","journal-title":"Br Med J"},{"key":"10.1016\/j.autrev.2010.02.006_bib8","doi-asserted-by":"crossref","first-page":"670","DOI":"10.7326\/0003-4819-150-10-200905190-00004","article-title":"Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis","volume":"150","author":"De Groot","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.autrev.2010.02.006_bib9","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/1529-0131(200005)43:5<1021::AID-ANR10>3.0.CO;2-J","article-title":"An interdisciplinary approach to the care of patients with Wegener's granulomatosis","volume":"43","author":"Reinhold-Keller","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2010.02.006_bib10","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/01.bor.0000200369.24793.f5","article-title":"Advances in the therapy of Wegener's granulomatosis","volume":"18","author":"Hellmich","year":"2006","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2010.02.006_bib11","doi-asserted-by":"crossref","first-page":"670","DOI":"10.7326\/0003-4819-150-10-200905190-00004","article-title":"Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis","volume":"150","author":"De Groot","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.autrev.2010.02.006_bib12","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/1529-0131(200005)43:5<1021::AID-ANR10>3.0.CO;2-J","article-title":"An interdisciplinary approach to the care of patients with Wegener's granulomatosis","volume":"43","author":"Reinhold-Keller","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2010.02.006_bib13","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.autrev.2008.01.003","article-title":"Membrane-bound proteinase 3 and its receptors: relevance for the pathogenesis of Wegener's Granulomatosis","volume":"8","author":"Hu","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2010.02.006_bib14","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1681\/ASN.V1061224","article-title":"A large subset of neutrophils expressing membrane proteinase 3 is a risk factor for vasculitis and rheumatoid arthritis","volume":"10","author":"Witko-Sarsat","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2010.02.006_bib15","doi-asserted-by":"crossref","first-page":"22320","DOI":"10.1097\/01.ASN.0000028642.26222.00","article-title":"Neutrophil membrane expression of proteinase 3 (PR3) is related to relapse in PR3-ANCA-associated vasculitis","volume":"13","author":"Rarok","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2010.02.006_bib16","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1681\/ASN.V12137","article-title":"Role of mitogen-activated protein kinases in activation of human neutrophils by antineutrophil cytoplasmic antibodies","volume":"12","author":"Kettritz","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.autrev.2010.02.006_bib17","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.4049\/jimmunol.153.3.1271","article-title":"Anti-neutrophil cytoplasmic autoantibodies engage and activate human neutrophils via Fc gamma RIIa","volume":"153","author":"Porges","year":"1994","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2010.02.006_bib18","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1073\/pnas.87.11.4115","article-title":"Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro","volume":"87","author":"Falk","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.autrev.2010.02.006_bib19","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1046\/j.1365-2567.1996.d01-711.x","article-title":"Priming differentially regulates neutrophil adhesion molecule expression\/function","volume":"89","author":"Condliff","year":"1996","journal-title":"Immunology"},{"key":"10.1016\/j.autrev.2010.02.006_bib20","first-page":"335","article-title":"Autoantibodies developing to MPO and PR3 in systemic vasculitis stimulate neutrophil cytotoxicity towards cultured endothelial cells","volume":"141","author":"Savage","year":"1992","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2010.02.006_bib21","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1681\/ASN.2007010090","article-title":"Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis","volume":"18","author":"Jayne","year":"2007","journal-title":"J Am Nephrol"},{"key":"10.1016\/j.autrev.2010.02.006_bib22","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/1529-0131(200005)43:5<1021::AID-ANR10>3.0.CO;2-J","article-title":"An interdisciplinary approach to the care of patients with Wegener's granulomatosis","volume":"43","author":"Reinhold-Keller","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2010.02.006_bib23","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1002\/art.21117","article-title":"Damage caused by Wegener's granulomatosis and its treatment. Prospective data from the Wegener's granulomatosis etanercept trial (WGET)","volume":"52","author":"Seo","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2010.02.006_bib24","first-page":"352","article-title":"Etanercept plus standard therapy for Wegener's Granulomatosis","volume":"352","year":"2005","journal-title":"N Eng J Med"},{"key":"10.1016\/j.autrev.2010.02.006_bib25","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1053\/gast.2001.28674","article-title":"Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial","volume":"121","author":"Sandborn","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2010.02.006_bib26","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/01.ASN.0000114554.67106.28","article-title":"Prospective study of TNFalpha blockade with infliximab in anti-neutrophil cytoplasmic antibody-associated systemic vasculitis","volume":"15","author":"Booth","year":"2004","journal-title":"J Am Nephrol"},{"key":"10.1016\/j.autrev.2010.02.006_bib27","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/art.20718","article-title":"Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis","volume":"52","author":"Keogh","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2010.02.006_bib28","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1080\/02813430510015269","article-title":"Anti-CD20 therapy of treatment resistant Wegener's granulomatosis: favourable but temporary response","volume":"34","author":"Omdal","year":"2005","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2010.02.006_bib29","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/RHU.0b013e31816b449e","article-title":"Rituximab and antineutrophil cytoplasmic antibody-associated vasculitis","volume":"14","author":"Wong","year":"2008","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.autrev.2010.02.006_bib30","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1136\/ard.2005.044420","article-title":"Lack of efficacy of rituximab in Wegener's granulomatosis with refractory granulomatous manifestations","volume":"65","author":"Aries","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2010.02.006_bib31","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1196\/annals.1361.042","article-title":"Is PR3-ANCA formation initiated in Wegener's granulomatosis lesions?","volume":"1051","author":"Voswinkel","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2010.02.006_bib32","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/1529-0131(199904)42:4<742::AID-ANR18>3.0.CO;2-I","article-title":"Cytokine profiles in Wegener's granulomatosis","volume":"42","author":"Csernok","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2010.02.006_bib33","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s12016-007-8056-8","article-title":"Pathways to ANCA production: from differentiation of dendritic cells by proteinase 3 to B lymphocyte maturation in Wegener's granuloma","volume":"34","author":"Csernok","year":"2008","journal-title":"Clinic Rev Allerg Immunol"},{"key":"10.1016\/j.autrev.2010.02.006_bib34","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1111\/j.1523-1755.2004.00534.x","article-title":"Treatment of refractory Wegener's granulomatosis with antithymocyte globulin (ATG): an open study in 15 patients","volume":"65","author":"Schmitt","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.autrev.2010.02.006_bib35","first-page":"473","article-title":"Refractory Wegener's granulomatosis: a model for shorter immunotherapy of autoimmune diseases","volume":"32","author":"Lockwood","year":"1998","journal-title":"J R Coll Physicians Lond"},{"key":"10.1016\/j.autrev.2010.02.006_bib36","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1056\/NEJMoa033402","article-title":"Anti-Interleukin-21 antibody for active Crohn's disease","volume":"351","author":"Mannon","year":"2004","journal-title":"New Eng J Med"},{"key":"10.1016\/j.autrev.2010.02.006_bib37","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1053\/j.gastro.2008.07.014","article-title":"A randomized trial of Ustekinumab, a human interleukin-12\/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease","volume":"135","author":"Sandborn","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2010.02.006_bib38","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.4049\/jimmunol.160.7.3602","article-title":"Active Wegener's granulomatosis is associated with HLA-DR+CD4+ T cells exhibiting an unbalanced Yh1-type T cell cytokine pattern: reversal with Il-10","volume":"160","author":"Ludviksson","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2010.02.006_bib39","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.arcmed.2009.04.001","article-title":"Intracellular cytokine production in ANCA-associated vasculitis: low levels of interleukin-10 in remission are associated with higher relapse rate in the long-term follow-up","volume":"40","author":"Hruskova","year":"2009","journal-title":"Arch Med Res"},{"key":"10.1016\/j.autrev.2010.02.006_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S146239940500921X","article-title":"Pathogenesis of Wegener's granulomatosis: current concepts","volume":"7","author":"Sharraf","year":"2005","journal-title":"Expert Rev Mol Med"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997210000194?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997210000194?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T07:24:20Z","timestamp":1685431460000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997210000194"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S1568997210000194"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2010.02.006","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}